These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 19729969

  • 1. Clinical assessment of tacrolimus therapy in lupus nephritis: one-year follow-up study in a single center.
    Asamiya Y, Uchida K, Otsubo S, Takei T, Nitta K.
    Nephron Clin Pract; 2009; 113(4):c330-6. PubMed ID: 19729969
    [Abstract] [Full Text] [Related]

  • 2. Management of young patients with lupus nephritis using tacrolimus administered as a single daily dose.
    Tanaka H, Oki E, Tsuruga K, Yashiro T, Hanada I, Ito E.
    Clin Nephrol; 2009 Dec; 72(6):430-6. PubMed ID: 19954719
    [Abstract] [Full Text] [Related]

  • 3. Effective treatment of young patients with pediatric-onset, long-standing lupus nephritis with tacrolimus given as a single daily dose: an open-label pilot study.
    Tanaka H, Oki E, Tsugawa K, Nonaka K, Suzuki K, Ito E.
    Lupus; 2007 Dec; 16(11):896-900. PubMed ID: 17971363
    [Abstract] [Full Text] [Related]

  • 4. Long-term tacrolimus-based immunosuppressive treatment for young patients with lupus nephritis: a prospective study in daily clinical practice.
    Tanaka H, Watanabe S, Aizawa-Yashiro T, Oki E, Kumagai N, Tsuruga K, Ito E.
    Nephron Clin Pract; 2012 Dec; 121(3-4):c165-73. PubMed ID: 23327881
    [Abstract] [Full Text] [Related]

  • 5. Tacrolimus is an alternative therapeutic option for the treatment of refractory lupus nephritis.
    Lee T, Oh KH, Joo KW, Kim YS, Ahn C, Han JS, Kim S, Chin HJ.
    Lupus; 2010 Jul; 19(8):974-80. PubMed ID: 20581020
    [Abstract] [Full Text] [Related]

  • 6. [Significance of serum anti-Clq Ab in evaluation of lupus nephritis activity and its curative effects of pharmacotherapy on lupus nephritis].
    Cai XY, Yang XY, Chen XH, Liang LQ, Guan MM, Qin SG, Fu JZ.
    Zhonghua Yi Xue Za Zhi; 2004 Sep 02; 84(17):1436-9. PubMed ID: 15500738
    [Abstract] [Full Text] [Related]

  • 7. Low-dose tacrolimus in treating lupus nephritis refractory to cyclophosphamide: a prospective cohort study.
    Fei Y, Wu Q, Zhang W, Chen H, Hou Y, Xu D, Li M, Zhang X, Zhao Y, Zeng X, Zhang F.
    Clin Exp Rheumatol; 2013 Sep 02; 31(1):62-8. PubMed ID: 22935463
    [Abstract] [Full Text] [Related]

  • 8. Tacrolimus for the treatment of systemic lupus erythematosus with pure class V nephritis.
    Szeto CC, Kwan BC, Lai FM, Tam LS, Li EK, Chow KM, Gang W, Li PK.
    Rheumatology (Oxford); 2008 Nov 02; 47(11):1678-81. PubMed ID: 18753192
    [Abstract] [Full Text] [Related]

  • 9. Tacrolimus in rheumatoid arthritis patients receiving concomitant methotrexate: a six-month, open-label study.
    Kremer JM, Habros JS, Kolba KS, Kaine JL, Borton MA, Mengle-Gaw LJ, Schwartz BD, Wisemandle W, Mekki QA, Tacrolimus-Methotrexate Rheumatoid Arthritis Study Group.
    Arthritis Rheum; 2003 Oct 02; 48(10):2763-8. PubMed ID: 14558080
    [Abstract] [Full Text] [Related]

  • 10. The efficacy of intravenous pulse cyclophosphamide in the treatment of severe lupus nephritis in children.
    Tangnararatchakit K, Tapaneya-Olarn C, Tapaneya-Olarn W.
    J Med Assoc Thai; 1999 Nov 02; 82 Suppl 1():S104-10. PubMed ID: 10730528
    [Abstract] [Full Text] [Related]

  • 11. [Comparison of various cyclophosphamide treatment regimens on the course and outcome of lupus nephritis ].
    Petrović R, Stojanović R, Novicić-Sasić D, Dimitrijević J, Pavlović S, Stojković D, Palić-Obradović D, Stevanović G, Prodanović S.
    Srp Arh Celok Lek; 2002 Aug 02; 130 Suppl 3():19-25. PubMed ID: 12583309
    [Abstract] [Full Text] [Related]

  • 12. Long-term effects of tacrolimus for maintenance therapy of lupus nephritis: a 5-year retrospective study at a single center.
    Karasawa K, Uchida K, Kodama M, Moriyama T, Nitta K.
    Rheumatol Int; 2018 Dec 02; 38(12):2271-2277. PubMed ID: 30203113
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial.
    Choudhry S, Bagga A, Hari P, Sharma S, Kalaivani M, Dinda A.
    Am J Kidney Dis; 2009 May 02; 53(5):760-9. PubMed ID: 19268410
    [Abstract] [Full Text] [Related]

  • 14. The prognosis of biopsy-proven lupus nephritis in chinese patients: long term follow-up of 86 cases.
    Shen K, Yu Y, Tang Z, Liu Z, Li L.
    Chin Med J (Engl); 1997 Jul 02; 110(7):502-7. PubMed ID: 9594205
    [Abstract] [Full Text] [Related]

  • 15. Outcomes of maintenance therapy with tacrolimus versus azathioprine for active lupus nephritis: a multicenter randomized clinical trial.
    Chen W, Liu Q, Chen W, Tang X, Fu P, Liu F, Liao Y, Yang Z, Zhang J, Chen J, Lou T, Fu J, Kong Y, Liu Z, Li Z, Yu X.
    Lupus; 2012 Aug 02; 21(9):944-52. PubMed ID: 22438027
    [Abstract] [Full Text] [Related]

  • 16. Treatment of lupus nephritis with cyclosporine - an outcome analysis.
    Rihova Z, Vankova Z, Maixnerova D, Dostal C, Jancova E, Honsova E, Merta M, Rysava R, Tesar V.
    Kidney Blood Press Res; 2007 Aug 02; 30(2):124-8. PubMed ID: 17396037
    [Abstract] [Full Text] [Related]

  • 17. Conversion to tacrolimus extended-release formulation: short-term clinical results.
    Gallego-Valcarce E, Ortega-Cerrato A, Llamas-Fuentes F, Martinez-Fernandez G, Perez-Martinez J, Gomez-Roldan C.
    Transplant Proc; 2009 Aug 02; 41(6):2326-7. PubMed ID: 19715909
    [Abstract] [Full Text] [Related]

  • 18. Safety of tacrolimus in patients with rheumatoid arthritis: long-term experience.
    Yocum DE, Furst DE, Bensen WG, Burch FX, Borton MA, Mengle-Gaw LJ, Schwartz BD, Wisememandle W, Mekki QA, Tacrolimus RA Study Group.
    Rheumatology (Oxford); 2004 Aug 02; 43(8):992-9. PubMed ID: 15014199
    [Abstract] [Full Text] [Related]

  • 19. Clinical, biochemical and pathological predictors of poor response to intravenous cyclophosphamide in patients with proliferative lupus nephritis.
    Conlon PJ, Fischer CA, Levesque MC, Smith SR, St Clair EW, Allen NB, Fleming JA, Howell DN.
    Clin Nephrol; 1996 Sep 02; 46(3):170-5. PubMed ID: 8879851
    [Abstract] [Full Text] [Related]

  • 20. Tacrolimus is safe and effective in patients with severe steroid-refractory or steroid-dependent inflammatory bowel disease--a long-term follow-up.
    Baumgart DC, Pintoffl JP, Sturm A, Wiedenmann B, Dignass AU.
    Am J Gastroenterol; 2006 May 02; 101(5):1048-56. PubMed ID: 16573777
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.